Skip to main content
. 2014 Nov 4;5(22):11091–11102. doi: 10.18632/oncotarget.2691

Figure 1. Study design.

Figure 1

CPCC=Chinese Prostate Cancer Consortium; PSA=prostate-specific antigen; ROC=receiver operating characteristic curve; DCA=decision curve analysis.